Niraparib Combined With Radiotherapy in rGBM

Clinical trial NCT04715620 · UNKNOWN

Trial details

NCT number: NCT04715620
Sponsor: Tianjin Huanhu Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2021-01-01
Primary completion: 2022-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.